Home › Squamous Cell Carcinoma › Missouri › St. Louis
Squamous Cell Carcinoma clinical trials in St. Louis, MO
6 studies for Squamous Cell Carcinoma are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- Washington University in St. Louis School of Medicine, St Louis
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
RecruitingPhase 2/3
- Washington University St. Louis, St Louis
Cemiplimab and Quad Shot Radiation for Cutaneous Squamous Cell Carcinoma in the Head and Neck
RecruitingEarly phase 1
- Washington University Medical Center, St Louis
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Research Site, St Louis
5-Fluorouracil Response and Optimization STudy (The FROST Trial)
RecruitingPhase 2
- Washington University School of Medicine, St Louis
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
- Siteman Cancer Center - Washington University, St Louis
Squamous Cell Carcinoma trials in other cities
- Pittsburgh, PA11 studies
- Los Angeles, CA9 studies
- Nashville, TN8 studies
- New York City, NY7 studies
- Boston, MA7 studies
- Houston, TX7 studies
- Durham, NC6 studies
- San Diego, CA6 studies
- Chicago, IL5 studies
- Queens, NY4 studies
- Washington, DC4 studies
- Orlando, FL4 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer68 studies
- Breast Cancer63 studies
- Metastatic Cancer52 studies
- Cancer (all types)51 studies
- Colorectal Cancer51 studies
- Prostate Cancer45 studies
- Ovarian Cancer37 studies
- Lung Cancer37 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma32 studies
- Endometrial Cancer29 studies
- Multiple Myeloma26 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.